An initial position was established in Omnicare, a pharmaceutical supply company, similar to a Walgreens. I learned of this company on CNBC, as a stock which had seen alot of recent call activity due to rumors of an acquisition. As such the premiums on the calls were pretty high. The purchase info is below.
4/27/2009 -- Bought 100 OCR @ 26.465
4/27/2009 -- Sold To Open 1 OCR May $27.50 Call @ 1.25
The important purchase metrics are below for insight into possible profit and loss (these all include commissions):
Stock Purchase Cost: $2646.50
If stock is called at expiration:
Downside Coverage: 4.7%
Possible Max Upside: 8.88%
Annualized Max Upside: 170.66%
Monday, April 27, 2009
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment